PortfoliosLab logoPortfoliosLab logo
KNSA vs. STRL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KNSA vs. STRL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kiniksa Pharmaceuticals, Ltd. (KNSA) and Sterling Infrastructure, Inc. (STRL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KNSA achieves a 33.60% return, which is significantly lower than STRL's 181.45% return.


KNSA

1D
1.66%
1M
3.51%
YTD
33.60%
6M
27.60%
1Y
93.78%
3Y*
52.43%
5Y*
29.69%
10Y*

STRL

1D
2.82%
1M
17.59%
YTD
181.45%
6M
179.31%
1Y
295.41%
3Y*
155.19%
5Y*
108.54%
10Y*
66.93%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KNSA vs. STRL - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
KNSA
Kiniksa Pharmaceuticals, Ltd.
33.60%108.54%12.77%17.09%27.27%-33.39%59.76%-60.63%14.89%
STRL
Sterling Infrastructure, Inc.
181.45%81.79%91.57%168.08%24.71%41.32%32.17%29.29%-13.57%

Correlation

The correlation between KNSA and STRL is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (All Time)
Calculated using the full available price history since May 24, 2018

0.18

Fundamentals

Market Cap

KNSA:

$4.54B

STRL:

$26.75B

EPS

KNSA:

$0.92

STRL:

$11.19

PE Ratio

KNSA:

59.85

STRL:

77.03

PEG Ratio

KNSA:

0.58

STRL:

1.64

PS Ratio

KNSA:

5.80

STRL:

9.26

PB Ratio

KNSA:

7.50

STRL:

22.49

Total Revenue (TTM)

KNSA:

$754.05M

STRL:

$2.88B

Gross Profit (TTM)

KNSA:

$294.06M

STRL:

$664.66M

EBITDA (TTM)

KNSA:

$101.06M

STRL:

$429.99M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KNSA vs. STRL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KNSA
KNSA Risk / Return Rank: 9292
Overall Rank
KNSA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
KNSA Sortino Ratio Rank: 9191
Sortino Ratio Rank
KNSA Omega Ratio Rank: 9090
Omega Ratio Rank
KNSA Calmar Ratio Rank: 9191
Calmar Ratio Rank
KNSA Martin Ratio Rank: 9494
Martin Ratio Rank

STRL
STRL Risk / Return Rank: 9696
Overall Rank
STRL Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
STRL Sortino Ratio Rank: 9494
Sortino Ratio Rank
STRL Omega Ratio Rank: 9494
Omega Ratio Rank
STRL Calmar Ratio Rank: 9797
Calmar Ratio Rank
STRL Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KNSA vs. STRL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and Sterling Infrastructure, Inc. (STRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KNSASTRLDifference
Sharpe ratioReturn per unit of total volatility

-1.21

Sortino ratioReturn per unit of downside risk

-0.52

Omega ratioGain probability vs. loss probability

1.41

1.51

-0.10

Calmar ratioReturn relative to maximum drawdown

4.63

9.25

-4.62

Martin ratioReturn relative to average drawdown

16.35

25.05

-8.70

KNSA vs. STRL - Sharpe Ratio Comparison

The current KNSA Sharpe Ratio is 2.27, which is lower than the STRL Sharpe Ratio of 3.49. The chart below compares the historical Sharpe Ratios of KNSA and STRL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KNSA vs. STRL - Drawdown Comparison

The maximum KNSA drawdown since its inception was -83.06%, smaller than the maximum STRL drawdown of -92.51%. Use the drawdown chart below to compare losses from any high point for KNSA and STRL.


Loading charts...

Drawdown Indicators


KNSASTRLDifference

Max Drawdown

Largest peak-to-trough decline

-83.06%

-92.51%

+9.45%

Max Drawdown (1Y)

Largest decline over 1 year

-21.12%

-31.02%

+9.90%

Max Drawdown (3Y)

Largest decline over 3 years

-34.14%

-47.67%

+13.53%

Max Drawdown (5Y)

Largest decline over 5 years

-53.17%

-47.67%

-5.50%

Max Drawdown (10Y)

Largest decline over 10 years

-59.60%

Current Drawdown

Current decline from peak

-7.35%

-13.27%

+5.92%

Average Drawdown

Average peak-to-trough decline

-40.60%

-46.27%

+5.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.97%

11.43%

-5.46%

Volatility

KNSA vs. STRL - Volatility Comparison

The current volatility for Kiniksa Pharmaceuticals, Ltd. (KNSA) is 10.40%, while Sterling Infrastructure, Inc. (STRL) has a volatility of 24.34%. This indicates that KNSA experiences smaller price fluctuations and is considered to be less risky than STRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KNSASTRLDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.40%

24.34%

-13.94%

Volatility (6M)

Calculated over the trailing 6-month period

34.02%

64.80%

-30.78%

Volatility (1Y)

Calculated over the trailing 1-year period

43.03%

82.30%

-39.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.48%

57.26%

-3.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.93%

53.55%

+10.38%

Dividends

KNSA vs. STRL - Dividend Comparison

Neither KNSA nor STRL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KNSA vs. STRL - Financials Comparison

This section allows you to compare key financial metrics between Kiniksa Pharmaceuticals, Ltd. and Sterling Infrastructure, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
214.27M
825.68M
(KNSA) Total Revenue
(STRL) Total Revenue
Values in USD except per share items

KNSA vs. STRL - Profitability Comparison

The chart below illustrates the profitability comparison between Kiniksa Pharmaceuticals, Ltd. and Sterling Infrastructure, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
23.5%
Portfolio components
KNSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.

STRL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sterling Infrastructure, Inc. reported a gross profit of 194.30M and revenue of 825.68M. Therefore, the gross margin over that period was 23.5%.

KNSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.

STRL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sterling Infrastructure, Inc. reported an operating income of 2.36M and revenue of 825.68M, resulting in an operating margin of 0.3%.

KNSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.

STRL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sterling Infrastructure, Inc. reported a net income of 95.97M and revenue of 825.68M, resulting in a net margin of 11.6%.


Frequently Asked Questions


KNSA and STRL have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

STRL has higher volatility (24.34%) compared to KNSA (10.40%). In terms of maximum drawdown, KNSA dropped -83.06% vs STRL's -92.51%.

STRL currently has the higher Sharpe Ratio (3.49 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KNSA and STRL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer